Literature DB >> 6693836

Murine tissue amyloid protein AA. NH2-terminal sequence identity with only one of two serum amyloid protein (ApoSAA) gene products.

J S Hoffman, L H Ericsson, N Eriksen, K A Walsh, E P Benditt.   

Abstract

Amyloid protein AA is the presumptive fragment of an acute phase serum apolipoprotein, apoSAA. Two major murine apoSAA isotypes (apoSAA1 and apoSAA2) have been identified. The NH2-terminal amino acid sequences of purified murine apoSAA1 and apoSAA2 have been examined and compared with that of murine amyloid protein AA. Our results indicate that apoSAA1 and apoSAA2 are separate gene products and that amyloid protein AA has NH2-terminal amino acid sequence identity with only one of these isotypes, namely apoSAA2.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6693836      PMCID： PMC2187226          DOI： 10.1084/jem.159.2.641

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  22 in total

1.  The complete amino-acid sequence of non-immunoglobulin amyloid fibril protein AS in rheumatoid arthritis.

Authors:  K Sletten; G Husby
Journal:  Eur J Biochem       Date:  1974-01-03

2.  Amino acid sequence of amyloid-related apoprotein (apoSAA1) from human high-density lipoprotein.

Authors:  D C Parmelee; K Titani; L H Ericsson; N Eriksen; E P Benditt; K A Walsh
Journal:  Biochemistry       Date:  1982-07-06       Impact factor: 3.162

3.  Mouse amyloid protein AA: Homology with nonimmunoglobulin protein of human and monkey amyloid substance.

Authors:  N Eriksen; L H Ericsson; N Pearsall; D Lagunoff; E P Benditt
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

4.  Amyloid protein SAA is associated with high density lipoprotein from human serum.

Authors:  E P Benditt; N Eriksen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

5.  Kinetics of serum amyloid protein A in casein-induced murine amyloidosis.

Authors:  M D Benson; M A Scheinberg; T Shirahama; E S Cathcart; M Skinner
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

6.  Isolation and partial characterization of SAA-an amyloid-related protein from human serum.

Authors:  C J Rosenthal; E C Franklin; B Frangione; J Greenspan
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

7.  Chemical classes of amyloid substance.

Authors:  E P Benditt; N Eriksen
Journal:  Am J Pathol       Date:  1971-10       Impact factor: 4.307

8.  Variation with age and disease of an amyloid A protein-related serum component.

Authors:  C J Rosenthal; E C Franklin
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

9.  Amyloid-related serum protein SAA from three animal species: comparison with human SAA.

Authors:  R F Anders; J B Natvig; K Sletten; G Husby; K Nordstoga
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

10.  Immunologic studies of the major nonimmunoglobulin protein of amyloid. I. Identification and partial characterization of a related serum component.

Authors:  M Levin; M Pras; E C Franklin
Journal:  J Exp Med       Date:  1973-08-01       Impact factor: 14.307
View more
  46 in total

1.  Inflammation protein SAA2.2 spontaneously forms marginally stable amyloid fibrils at physiological temperature.

Authors:  Zhuqiu Ye; Diane Bayron Poueymiroy; J Javier Aguilera; Saipraveen Srinivasan; Yun Wang; Louise C Serpell; Wilfredo Colón
Journal:  Biochemistry       Date:  2011-10-05       Impact factor: 3.162

2.  Alzheimer's disease brain-derived ubiquitin has amyloid-enhancing factor activity: behavior of ubiquitin during accelerated amyloidogenesis.

Authors:  K Alizadeh-Khiavi; J Normand; S Chronopoulos; Z Ali-Khan
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

3.  Regulation of mouse serum amyloid A gene expression in transfected hepatoma cells.

Authors:  J H Huang; H Y Rienhoff; W S Liao
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

4.  Human serum amyloid A protein. Behaviour in aqueous and urea-containing solutions and antibody production.

Authors:  A F Strachan; E G Shephard; D U Bellstedt; G A Coetzee; D R van der Westhuyzen; F C de Beer
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

5.  Diagnosis of the type of amyloid in paraffin wax embedded tissue sections using antisera against human and animal amyloid proteins.

Authors:  C A van de Kaa; P R Hol; J Huber; R P Linke; C J Kooiker; E Gruys
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

6.  Influence of the carboxy terminus of serum amyloid A on protein oligomerization, misfolding, and fibril formation.

Authors:  Sanket Patke; Ronak Maheshwari; Jeffrey Litt; Saipraveen Srinivasan; J Javier Aguilera; Wilfredo Colón; Ravi S Kane
Journal:  Biochemistry       Date:  2012-03-26       Impact factor: 3.162

7.  Serum amyloid A in the mouse. Sites of uptake and mRNA expression.

Authors:  R L Meek; N Eriksen; E P Benditt
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

8.  Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils.

Authors:  K Johan; G Westermark; U Engström; A Gustavsson; P Hultman; P Westermark
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

9.  Human serum amyloid A. Three hepatic mRNAs and the corresponding proteins in one person.

Authors:  B Kluve-Beckerman; F E Dwulet; M D Benson
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

10.  Fibrils from designed non-amyloid-related synthetic peptides induce AA-amyloidosis during inflammation in an animal model.

Authors:  Per Westermark; Katarzyna Lundmark; Gunilla T Westermark
Journal:  PLoS One       Date:  2009-06-30       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.